Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.

Jeffrey R. Keefer, Tonya A. Schneidereith, Abbie Mays, Shirley H. Purvis, George J. Dover, Kirby D. Smith

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: In vivo, several drugs have been shown to increase fetal hemoglobin (HbF), including 5-azacytidine (AZA), sodium butyrate (SB), and hydroxyurea (HU). Studies in K562 cells suggest that cyclic guanosine monophosphate (cGMP) is required for HbF induction; however, the role of cyclic nucleotides in HbF induction in primary erythroid cultures has not been established. METHODS: CD34-selected peripheral blood monocytes cultured in a semi-solid serum-free system that mimics in vivo F-cell production are utilized to explore the role of cyclic adenosine monophosphate (cAMP) and cGMP in HbF induction in response to HU, AZA, and SB. RESULTS: In serum-free CD34 cultures, HU, SB, and AZA all markedly stimulate FNRBC production up to 30-fold, associated with induction of gamma-globin mRNA and total HbF protein. Guanylate cyclase inhibition results in only minimal blunting of HbF induction by each agent. In contrast, adenylate cyclase inhibition markedly reduces HU, SB, and AZA-mediated FNRBC induction and gamma-globin mRNA induction. The adenylate cyclase activator forskolin modestly induces FNRBC production and augments the action of standard induction agents. HU, AZA, and SB, however, fail to significantly stimulate adenylate cyclase themselves. CONCLUSIONS: In human CD34(+) cultures, cAMP production is required for full induction of HbF by HU, SB, and AZA, while perturbation of cGMP production has only minimal effects. These findings are in marked contrast to data in K562 cells where cGMP production is critical for HbF induction while cAMP stimulation blunts HbF response, and suggest that these agents may share a common induction pathway.

Original languageEnglish (US)
Pages (from-to)1151-1161
Number of pages11
JournalExperimental Hematology
Volume34
Issue number9
StatePublished - Sep 2006

Fingerprint

Azacitidine
Fetal Hemoglobin
Butyric Acid
Hydroxyurea
Cyclic Nucleotides
Cultured Cells
Cyclic GMP
Adenylyl Cyclases
gamma-Globins
K562 Cells
Cyclic AMP
Messenger RNA
Guanylate Cyclase
Colforsin
Serum
Monocytes
Pharmaceutical Preparations
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. / Keefer, Jeffrey R.; Schneidereith, Tonya A.; Mays, Abbie; Purvis, Shirley H.; Dover, George J.; Smith, Kirby D.

In: Experimental Hematology, Vol. 34, No. 9, 09.2006, p. 1151-1161.

Research output: Contribution to journalArticle

Keefer, Jeffrey R. ; Schneidereith, Tonya A. ; Mays, Abbie ; Purvis, Shirley H. ; Dover, George J. ; Smith, Kirby D. / Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. In: Experimental Hematology. 2006 ; Vol. 34, No. 9. pp. 1151-1161.
@article{2a1e5c7c751843519eaf788dd55d0f43,
title = "Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.",
abstract = "OBJECTIVE: In vivo, several drugs have been shown to increase fetal hemoglobin (HbF), including 5-azacytidine (AZA), sodium butyrate (SB), and hydroxyurea (HU). Studies in K562 cells suggest that cyclic guanosine monophosphate (cGMP) is required for HbF induction; however, the role of cyclic nucleotides in HbF induction in primary erythroid cultures has not been established. METHODS: CD34-selected peripheral blood monocytes cultured in a semi-solid serum-free system that mimics in vivo F-cell production are utilized to explore the role of cyclic adenosine monophosphate (cAMP) and cGMP in HbF induction in response to HU, AZA, and SB. RESULTS: In serum-free CD34 cultures, HU, SB, and AZA all markedly stimulate FNRBC production up to 30-fold, associated with induction of gamma-globin mRNA and total HbF protein. Guanylate cyclase inhibition results in only minimal blunting of HbF induction by each agent. In contrast, adenylate cyclase inhibition markedly reduces HU, SB, and AZA-mediated FNRBC induction and gamma-globin mRNA induction. The adenylate cyclase activator forskolin modestly induces FNRBC production and augments the action of standard induction agents. HU, AZA, and SB, however, fail to significantly stimulate adenylate cyclase themselves. CONCLUSIONS: In human CD34(+) cultures, cAMP production is required for full induction of HbF by HU, SB, and AZA, while perturbation of cGMP production has only minimal effects. These findings are in marked contrast to data in K562 cells where cGMP production is critical for HbF induction while cAMP stimulation blunts HbF response, and suggest that these agents may share a common induction pathway.",
author = "Keefer, {Jeffrey R.} and Schneidereith, {Tonya A.} and Abbie Mays and Purvis, {Shirley H.} and Dover, {George J.} and Smith, {Kirby D.}",
year = "2006",
month = "9",
language = "English (US)",
volume = "34",
pages = "1151--1161",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.

AU - Keefer, Jeffrey R.

AU - Schneidereith, Tonya A.

AU - Mays, Abbie

AU - Purvis, Shirley H.

AU - Dover, George J.

AU - Smith, Kirby D.

PY - 2006/9

Y1 - 2006/9

N2 - OBJECTIVE: In vivo, several drugs have been shown to increase fetal hemoglobin (HbF), including 5-azacytidine (AZA), sodium butyrate (SB), and hydroxyurea (HU). Studies in K562 cells suggest that cyclic guanosine monophosphate (cGMP) is required for HbF induction; however, the role of cyclic nucleotides in HbF induction in primary erythroid cultures has not been established. METHODS: CD34-selected peripheral blood monocytes cultured in a semi-solid serum-free system that mimics in vivo F-cell production are utilized to explore the role of cyclic adenosine monophosphate (cAMP) and cGMP in HbF induction in response to HU, AZA, and SB. RESULTS: In serum-free CD34 cultures, HU, SB, and AZA all markedly stimulate FNRBC production up to 30-fold, associated with induction of gamma-globin mRNA and total HbF protein. Guanylate cyclase inhibition results in only minimal blunting of HbF induction by each agent. In contrast, adenylate cyclase inhibition markedly reduces HU, SB, and AZA-mediated FNRBC induction and gamma-globin mRNA induction. The adenylate cyclase activator forskolin modestly induces FNRBC production and augments the action of standard induction agents. HU, AZA, and SB, however, fail to significantly stimulate adenylate cyclase themselves. CONCLUSIONS: In human CD34(+) cultures, cAMP production is required for full induction of HbF by HU, SB, and AZA, while perturbation of cGMP production has only minimal effects. These findings are in marked contrast to data in K562 cells where cGMP production is critical for HbF induction while cAMP stimulation blunts HbF response, and suggest that these agents may share a common induction pathway.

AB - OBJECTIVE: In vivo, several drugs have been shown to increase fetal hemoglobin (HbF), including 5-azacytidine (AZA), sodium butyrate (SB), and hydroxyurea (HU). Studies in K562 cells suggest that cyclic guanosine monophosphate (cGMP) is required for HbF induction; however, the role of cyclic nucleotides in HbF induction in primary erythroid cultures has not been established. METHODS: CD34-selected peripheral blood monocytes cultured in a semi-solid serum-free system that mimics in vivo F-cell production are utilized to explore the role of cyclic adenosine monophosphate (cAMP) and cGMP in HbF induction in response to HU, AZA, and SB. RESULTS: In serum-free CD34 cultures, HU, SB, and AZA all markedly stimulate FNRBC production up to 30-fold, associated with induction of gamma-globin mRNA and total HbF protein. Guanylate cyclase inhibition results in only minimal blunting of HbF induction by each agent. In contrast, adenylate cyclase inhibition markedly reduces HU, SB, and AZA-mediated FNRBC induction and gamma-globin mRNA induction. The adenylate cyclase activator forskolin modestly induces FNRBC production and augments the action of standard induction agents. HU, AZA, and SB, however, fail to significantly stimulate adenylate cyclase themselves. CONCLUSIONS: In human CD34(+) cultures, cAMP production is required for full induction of HbF by HU, SB, and AZA, while perturbation of cGMP production has only minimal effects. These findings are in marked contrast to data in K562 cells where cGMP production is critical for HbF induction while cAMP stimulation blunts HbF response, and suggest that these agents may share a common induction pathway.

UR - http://www.scopus.com/inward/record.url?scp=33750630895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750630895&partnerID=8YFLogxK

M3 - Article

C2 - 16939808

VL - 34

SP - 1151

EP - 1161

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -